USD
$0.00
(0.00%
)At Close (As of Dec 11, 2025)
-
Market Cap
-
P/E Ratio
-
EPS
$13.68
52 Week High
$1.90
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | -$112K |
| Total Revenue | $4.4M |
| Cost Of Revenue | $4.5M |
| Costof Goods And Services Sold | $4.5M |
| Operating Income | -$14M |
| Selling General And Administrative | $10M |
| Research And Development | $3.4M |
| Operating Expenses | $14M |
| Investment Income Net | - |
| Net Interest Income | -$3.1M |
| Interest Income | $0 |
| Interest Expense | $3.1M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $543K |
| Income Before Tax | -$21M |
| Income Tax Expense | -$15K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$21M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$18M |
| Ebitda | -$17M |
| Net Income | -$21M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$12M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $543K |
| Capital Expenditures | $0 |
| Change In Receivables | - |
| Change In Inventory | -$1.3M |
| Profit Loss | - |
| Cashflow From Investment | - |
| Cashflow From Financing | $12M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$21M |
| Field | Value (USD) |
|---|---|
| Gross Profit | -$112K |
| Total Revenue | $4.4M |
| Cost Of Revenue | $4.5M |
| Costof Goods And Services Sold | $4.5M |
| Operating Income | -$14M |
| Selling General And Administrative | $10M |
| Research And Development | $3.4M |
| Operating Expenses | $14M |
| Investment Income Net | - |
| Net Interest Income | -$3.1M |
| Interest Income | $0 |
| Interest Expense | $3.1M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $543K |
| Income Before Tax | -$21M |
| Income Tax Expense | -$15K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$21M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$18M |
| Ebitda | -$17M |
| Net Income | -$21M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Picard Medical, Inc. is a pioneering force in the medical device sector, dedicated to the design, manufacturing, and marketing of innovative healthcare solutions that significantly enhance patient care. With a diverse product portfolio, the company leverages cutting-edge technology to transform medical practices and improve clinical outcomes, establishing itself as a prominent player in the dynamic healthcare landscape. Through strategic alliances and a strong commitment to research and development, Picard Medical continuously advances the frontiers of medical technology, delivering high-quality solutions tailored to the needs of healthcare providers.